Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
Friday, April 21, 2017Sawai Pharmaceutical Co Ltd a leading Japanese generic pharmaceuticals manufacturer and UpsherSmith Laboratories Inc UpsherSmith an established generics manufacturer based in Minnesota US today announced the signing of an agreement for Sawai to purch...
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sarcomas
Thursday, April 20, 2017CytRx Corporation announced the US Food and Drug Administration FDA has reached an agreement with CytRx on preparations for a New Drug Application NDA submission for aldoxorubicin in soft tissue sarcomas STS STS remains a high unmet medical need W...
Actis portfolio company MédiS Group announces the acquisition of Winthrop Pharma Senegal from Sanofi
Thursday, April 20, 2017Actis a leading growth markets investor today announced that its portfolio company MdiS a major pharmaceutical company based in Tunisia has acquired Winthrop Pharma Senegal WPS from Sanofi Actis invested in MdiS at the end of August with the visi...
Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases
Thursday, April 20, 2017Boehringer Ingelheim Pharmaceuticals Inc today announced that the first patient has been enrolled in the PFILD progressive fibrosing interstitial lung disease trial This study investigates the efficacy and safety of nintedanib in a range of progressi...
Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc. Agree to Combine
Wednesday, April 19, 2017Nivalis Therapeutics Inc and Alpine Immune Sciences Inc a privatelyheld biotechnology company developing novel therapies using its nextgeneration immune system modulation platform today jointly announced they have entered into a definitive merger agr...
Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China
Wednesday, April 19, 2017Ionis Pharmaceuticals Inc announced a collaboration and license agreement with Suzhou Ribo Life Science Co Ltd Ribo to develop and commercialize RNAtargeted therapeutics in China Ionis granted Ribo a license for the right to commercialize in China tw...
Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP
Tuesday, April 18, 2017Rigel Pharmaceuticals Inc announced that it has submitted a New Drug Application NDA to the US Food and Drug Administration FDA for fostamatinib in patients with chronic and persistent immune thrombocytopenia ITP This NDA submission in support of...
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Tuesday, April 18, 2017Allergan a leading global biopharmaceutical company announced today that it has entered into a clinical trial agreement with Novartis to conduct a Phase b study using Allergans cenicriviroc CVC and Novartis lead FXR agonist for the treatment of nonal...
LegoChem Biosciences Receives US Patent for Its Own Proprietary ADC Platform Technology ConjuAllTM
Monday, April 17, 2017LegoChem Biosciences a biopharmaceutical company focusing on the research development of ADCs based in Daejeon South Korea announced today that the Company was awarded US Patent No entitled ANTIBODYACTIVE AGENT CONJUGATES AND METHODS OF USE The...
Genentech Announces Positive Interim Results for Emicizumab in Phase III Study of Children with Hemophilia A
Monday, April 17, 2017Genentech a member of the Roche Group today announced interim results from the Phase III HAVEN study evaluating emicizumab prophylaxis in children less than years of age with hemophilia A and inhibitors to factor VIII At this interim analysis after...
